Go to deals
Consumer & Retail | Private Equity

Enaltus, LLC has sold its brand ScarAway® to Perrigo Company plc

August 2015 — Enaltus, LLC, a portfolio company of HealthEdge Investment Partners, LLC, has sold ScarAway®, a leading US over-the-counter (OTC) scar management brand, to Perrigo Company plc. Financial details have not been disclosed.

ScarAway® is a market leader in the scar management category in the OTC consumer channel. It is the fastest-growing brand in the category and is currently the number one 100% silicone scar treatment brand and the number two brand in the overall consumer scar category in the US. ScarAway® provides a complete range of scar management solutions, including gels, serum and long and short fabric-backed silicone sheets. The brand has distribution across all retailers in the drug, mass, food, specialty and e-commerce channels, with a presence in more than 35,000 doors in the US.

Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company plc (NYSE:PRGO), together with its subsidiaries, develops, manufactures, markets, and distributes OTC consumer goods and pharmaceutical products worldwide. It offers its products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company sells its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, parapharmacies and hospitals as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America.

Founded in 1995 and based in Suwanee, Georgia, Enaltus develops, manufactures and markets skincare products for professional and consumer markets primarily for mothers and babies in the US and internationally. The company’s products include Kelo-cote, a topical silicone gel and spray for the treatment and prevention of abnormal scars, including hypertrophic scars and keloids; bioCorneum, a silicone treatment for minimizing the appearance of scars; Belli, a skincare cosmetic for expecting and nursing mothers, and babies; and CapriClear Moisturizing Spray, a solution that provides relief from dry, flaky, and irritated skin. Enaltus also offers Arnika Forte, a natural supplement for recovering from bruising, swelling, and pain associated with soft tissue injuries. The company serves physicians, plastic surgeons, dermatologists, OB/GYN’s and others. It offers its products directly to physicians and consumers as well as through national and independent retailers.

Our role in the transaction

Oaklins' team in Los Angeles acted as advisor to Enaltus, LLC in this transaction.

Parties

Talk to the deal team

Steven Davis

Managing Director
Los Angeles, United States
Oaklins Intrepid

Brian Levin

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Private Equity | Consumer & Retail | Real Estate

Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate

Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.

Learn more
OEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value
Private Equity | TMT

OEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value

OEP Danzig BidCo S.p.A. has completed a mandatory tender offer for the shares of Digital Value S.p.A.

Learn more
Bolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Private Equity | Food & Beverage

Bolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company

Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.

Learn more